French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

LAUSANNE - ADC Therapeutics SA (NYSE: ADCT), a biotechnology firm specializing in antibody drug conjugates (ADCs), has reported positive preliminary results from a clinical trial assessing the ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the ...

In view of the above, I decided to drop my membership in the African Democratic Congress ADC party.” While lauding the support of his teeming supporters, Garba said he will announce his next ...

Duality Biologics has shared the first data from a phase 1/2a antibody-drug conjugate (ADC) trial, giving an early look at how the BioNTech-partnered asset is shaping up against rival molecules in ...

LAUSANNE - ADC Therapeutics SA (NYSE: ADCT), a biotechnology firm specializing in antibody drug conjugates (ADCs), has reported positive preliminary results from a clinical trial assessing the ...